AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35268055 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of brisk walking after meals with different carbohydrate content (0.75 or 1.5 g of CHO per kg/body weight)
Number of subjects: 21
Study 35268055 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of brisk walking after consuming a mixed meal or a CHO drink matched for absolute CHO content (75 g)
Number of subjects: 21
Study 35268055 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of brisk walking after lower CHO content meals
Number of subjects: 21
Study 35268055 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of brisk walking after a mixed meal or a CHO drink
Number of subjects: 21
Study 33305662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline combined with hormone therapy standard schemes
Number of subjects: 227
Study 33305662 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 227
Study 36089471 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1/mRNA-1273 8 weeks apart
Number of subjects: 399
Study 36089471 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273/mRNA-1273 4 weeks apart
Number of subjects: 399
Study 33308427 — intervention group
Group type: COMPARATOR
Intervention: Monovalent OPV2
Number of subjects: 834
Study 33308427 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose novel OPV2-c1
Number of subjects: 834
Study 33308427 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose novel OPV2-c1
Number of subjects: 834
Study 33308427 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose novel OPV2-c2
Number of subjects: 834
Study 33308427 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose novel OPV2-c2
Number of subjects: 834
Study 36468784 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop automated insulin delivery (MiniMed 670G)
Number of subjects: 21
Study 36468784 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy
Number of subjects: 21
Study 33230718 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive toilet training session (2-hour training on two consecutive days in small groups)
Number of subjects: 0
Study 33230718 — intervention group
Group type: COMPARATOR
Intervention: Control group (parents encouraged to start toilet training in their own manner)
Number of subjects: 0
Study 33230718 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive toilet training session
Number of subjects: 0
Study 35791704 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexpanthenol ampoule 250 mg/2 ml and biotin ampoule 5 mg/1 ml (Pars Behvarzan)
Number of subjects: 50
Study 35791704 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexpanthenol ampoule 250 mg/2 ml and biotin ampoule 5 mg/1 ml (Bayer Company)
Number of subjects: 50
Study 32157691 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep restriction (6.5 hr in bed)
Number of subjects: 48
Study 32157691 — intervention group
Group type: COMPARATOR
Intervention: Sleep extension (9.5 hr in bed)
Number of subjects: 48
Study 35334797 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (75 mg of Cr monohydrate·kg−1·day−1)
Number of subjects: 16
Study 35334797 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation (75 mg of glucose·kg−1·day−1)
Number of subjects: 16
Study 33559067 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated enrollment with dedicated outreach to encourage use of the PCD tool (PatientWisdom)
Number of subjects: 301
Study 33559067 — intervention group
Group type: COMPARATOR
Intervention: Standard pre-visit email
Number of subjects: 301
Study 35428348 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha/Theta Neurofeedback
Number of subjects: 15
Study 34704430 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceratonia siliqua (Carob) capsules, 500 mg, taken daily for 90 days
Number of subjects: 50
Study 34704430 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E capsules, taken three times a day for 90 days
Number of subjects: 50
Study 35975547 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose AD109 (75/2.5 mg)
Number of subjects: 0
Study 35975547 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose AD109 (37.5/2.5 mg)
Number of subjects: 0
Study 35975547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33735632 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzymatic immunoassay test
Number of subjects: 500
Study 33735632 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid-liquid extraction method with LC-MS/MS
Number of subjects: 500
Study 33735632 — intervention group
Group type: COMPARATOR
Intervention: Immunoassay screening tests
Number of subjects: 500
Study 33338364 — intervention group
Group type: EXPERIMENTAL
Intervention: Early childhood caries (ECC) prevalence assessment
Number of subjects: 341
Study 33338364 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of initial caries lesions
Number of subjects: 341
Study 33338364 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by gender and language
Number of subjects: 341
Study 33338364 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by parental employment
Number of subjects: 341
Study 33338364 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by parental education
Number of subjects: 341
Study 33338364 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by family income
Number of subjects: 341
Study 33338364 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by ethnicity
Number of subjects: 341
Study 34935139 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus capecitabine (GEMCAP)
Number of subjects: 778
Study 34935139 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine monotherapy (GEM)
Number of subjects: 778
Study 32777552 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 55
Study 32777552 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 55
Study 34321048 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/d whole meat GSM powder
Number of subjects: 50
Study 34321048 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sunflower seed protein)
Number of subjects: 50
Study 36068945 — intervention group
Group type: EXPERIMENTAL
Intervention: Keverprazan 20 mg
Number of subjects: 180
Study 36068945 — intervention group
Group type: EXPERIMENTAL
Intervention: Keverprazan 30 mg
Number of subjects: 180
Study 36068945 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 30 mg
Number of subjects: 180
Study 34311022 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 195
Study 34311022 — intervention group
Group type: COMPARATOR
Intervention: Sulphonylureas
Number of subjects: 195
Study 32641337 — intervention group
Group type: EXPERIMENTAL
Intervention: FitSkills intervention (exercise with a student mentor at local gym for 1 hour, two times per week for 12 weeks)
Number of subjects: 160
Study 32641337 — intervention group
Group type: COMPARATOR
Intervention: Control phase (no specific intervention details provided)
Number of subjects: 160
Study 33439574 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram incorporating serum neutrophil-to-lymphocyte ratio (NLR) as a predictor of spontaneous stone passage (SSP)
Number of subjects: 1186
Study 33772947 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 412
Study 32546963 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib (750 mg daily from Day 9-21)
Number of subjects: 0
Study 34687240 — intervention group
Group type: EXPERIMENTAL
Intervention: Do-it-yourself continuous glucose monitor (DIYrtCGM) with technical support
Number of subjects: 11
Study 34687240 — intervention group
Group type: EXPERIMENTAL
Intervention: Do-it-yourself continuous glucose monitor (DIYrtCGM)
Number of subjects: 11
Study 33150424 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel flyer with simple and positive framing
Number of subjects: 1070
Study 32289853 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombin injection
Number of subjects: 68
Study 32289853 — intervention group
Group type: COMPARATOR
Intervention: Glue injection
Number of subjects: 68
Study 35291270 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium high potassium (LSHP) diet
Number of subjects: 70
Study 35291270 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (control)
Number of subjects: 70
Study 34641839 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program (including occupational therapy and reintegration consultation)
Number of subjects: 236
Study 34641839 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 236
Study 34641839 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohort study for partners of cancer survivors
Number of subjects: 236
Study 32169259 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor exercises (three 60‐min sessions per week for 8 weeks)
Number of subjects: 30
Study 32169259 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 33949031 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based physical activity intervention
Number of subjects: 76
Study 34238342 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) granules combined with chemotherapy
Number of subjects: 270
Study 34238342 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (placebo control)
Number of subjects: 270
Study 35103766 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate hypothermia (33‐34 °C; n=168)
Number of subjects: 374
Study 35103766 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (36‐37 °C; n=166)
Number of subjects: 374
Study 35103766 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate hypothermia (33‐34 °C)
Number of subjects: 374
Study 35103766 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (36‐37 °C)
Number of subjects: 374
Study 32451125 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 120
Study 32451125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 34719004 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500 mg, twice daily)
Number of subjects: 154
Study 34719004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 32029547 — intervention group
Group type: EXPERIMENTAL
Intervention: noninvasive vagus nerve stimulation (nVNS)
Number of subjects: 21
Study 32029547 — intervention group
Group type: COMPARATOR
Intervention: sham vagus nerve stimulation
Number of subjects: 21
Study 36156108 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional nicotine with menthol
Number of subjects: 263
Study 36156108 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional nicotine cigarette with no menthol
Number of subjects: 263
Study 36156108 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette with reduced nicotine (RNC) with menthol
Number of subjects: 263
Study 36156108 — intervention group
Group type: EXPERIMENTAL
Intervention: RNC cigarette and no menthol
Number of subjects: 263
Study 36156108 — intervention group
Group type: COMPARATOR
Intervention: Own brand of cigarette (conventional nicotine with menthol)
Number of subjects: 263
Study 36156108 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-menthol and/or RNC cigarettes
Number of subjects: 263
Study 33928452 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (total number of B-lines)
Number of subjects: 10
Study 33928452 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferior vena cava collapsibility index (cIVC)
Number of subjects: 10
Study 33928452 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of lung ultrasound and cIVC
Number of subjects: 10
Study 32437567 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) 0.5 mg per day plus Biejia-Ruangan (BR) 2 g 3 times a day for 72 weeks
Number of subjects: 1000
Study 32437567 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) 0.5 mg per day plus Biejia-Ruangan (BR)
Number of subjects: 1000
Study 32437567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 33691454 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof® IQ Toric IOL
Number of subjects: 20
Study 33691454 — intervention group
Group type: COMPARATOR
Intervention: AcrySof® IQ IOL with steep-axis incision
Number of subjects: 20
Study 32572064 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% bromelain-based whitening
Number of subjects: 40
Study 32572064 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% ficin-based whitening
Number of subjects: 40
Study 32572064 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% papain-based whitening
Number of subjects: 40
Study 32572064 — intervention group
Group type: COMPARATOR
Intervention: 20 wt% carbamide peroxide (control)
Number of subjects: 40
Study 35413886 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of 1.5-g meropenem resolved in 30-ml saline given via central line for 30 min, followed by 0.75-g meropenem every 8 h for 30 min.
Number of subjects: 120
Study 35413886 — intervention group
Group type: COMPARATOR
Intervention: 0.75-g meropenem for 30 min every 8 h (Control group).
Number of subjects: 120
Study 35413886 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of 1.5-g meropenem.
Number of subjects: 120
Study 33855805 — intervention group
Group type: EXPERIMENTAL
Intervention: Iptakalim hydrochloride (ITKL) 5, 10, 15, and 20 mg single oral administration; 10 and 20 mg multiple oral administration
Number of subjects: 83
Study 33855805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 32891342 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumescent technique
Number of subjects: 357
Study 32891342 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery technique
Number of subjects: 357
Study 35385137 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 60
Study 35385137 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 60
Study 34441930 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate invasive treatment strategy (<3 h)
Number of subjects: 249
Study 34441930 — intervention group
Group type: COMPARATOR
Intervention: Early invasive treatment strategy (12–24 h)
Number of subjects: 249
Study 35667715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cevira (hexaminolevulinate photodynamic therapy)
Number of subjects: 384
Study 35667715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study 33204086 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium dioxide-coated stainless steel orthodontic wires
Number of subjects: 68
Study 33204086 — intervention group
Group type: COMPARATOR
Intervention: Uncoated stainless steel orthodontic wires (Control)
Number of subjects: 68
Study 33742550 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittently scanned continuous glucose monitoring system
Number of subjects: 0
Study 35871148 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal guidance combined with a comic book (Intervention Group - IG)
Number of subjects: 120
Study 35871148 — intervention group
Group type: COMPARATOR
Intervention: Verbal guidance by nurses (Control Group - CG)
Number of subjects: 120
Study 35871148 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IG and CG
Number of subjects: 120
Study 34351693 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional tuberculin immunotherapy
Number of subjects: 30
Study 34351693 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 30
Study 35527126 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus physical activity
Number of subjects: 121
Study 35527126 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet only
Number of subjects: 121
Study 35527126 — intervention group
Group type: COMPARATOR
Intervention: Lean control group
Number of subjects: 121
Study 33867298 — intervention group
Group type: EXPERIMENTAL
Intervention: Email survey alone
Number of subjects: 72
Study 33867298 — intervention group
Group type: EXPERIMENTAL
Intervention: Email survey + telephone reminder
Number of subjects: 72
Study 33867298 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 72
Study 33867298 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 72
Study 34880074 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) after rituximab
Number of subjects: 39
Study 34880074 — intervention group
Group type: COMPARATOR
Intervention: Rituximab monotherapy
Number of subjects: 39
Study 33942655 — intervention group
Group type: EXPERIMENTAL
Intervention: 4F-PCC
Number of subjects: 58
Study 33942655 — intervention group
Group type: COMPARATOR
Intervention: Standard of care therapies
Number of subjects: 58
Study 32530900 — intervention group
Group type: EXPERIMENTAL
Intervention: Branching Path Simulation (BPS)
Number of subjects: 0
Study 32530900 — intervention group
Group type: COMPARATOR
Intervention: Regular Lectures (RL)
Number of subjects: 0
Study 33025243 — intervention group
Group type: EXPERIMENTAL
Intervention: Zilver PTX drug-eluting stent (DES) treatment
Number of subjects: 2227
Study 33025243 — intervention group
Group type: EXPERIMENTAL
Intervention: Example patient profiles
Number of subjects: 2227
Study 33063619 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic warning messages campaign
Number of subjects: 1392
Study 33665467 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized antibiotic prescription feedback and evidence-based treatment guidelines including region-specific antibiotic resistance information, provided quarterly for two years.
Number of subjects: 3426
Study 33665467 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized antibiotic prescription feedback and evidence-based treatment guidelines.
Number of subjects: 3426
Study 33665467 — intervention group
Group type: COMPARATOR
Intervention: Control group with no intervention.
Number of subjects: 3426
Study 608561422 — intervention group
Group type: EXPERIMENTAL
Intervention: Community exposure to CHW integrated primary health-care services
Number of subjects: 0
Study 608561422 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW programme introduction
Number of subjects: 0
Study 608561422 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordination with health system efforts
Number of subjects: 0
Study 35700976 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized RTF-velocity relationships
Number of subjects: 23
Study 35700976 — intervention group
Group type: COMPARATOR
Intervention: Generalized RTF-velocity relationships
Number of subjects: 23
Study 35700976 — intervention group
Group type: EXPERIMENTAL
Intervention: Velocity values associated with different RTFs
Number of subjects: 23
Study 35700976 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction of RTF under fatigue
Number of subjects: 23
Study 34668671 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention pharmacies (pharmacist-led intervention)
Number of subjects: 0
Study 34668671 — intervention group
Group type: COMPARATOR
Intervention: Control pharmacies
Number of subjects: 0
Study 32468883 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education with mind mapping
Number of subjects: 159
Study 32468883 — intervention group
Group type: COMPARATOR
Intervention: Health education without mind mapping (Control)
Number of subjects: 159
Study 35841944 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-based LLT intensification alert
Number of subjects: 2500
Study 35841944 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2500
Study 32820698 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 95
Study 32820698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 36012027 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally and linguistically appropriate food education program based on the Transtheoretical model, 10 weekly sessions
Number of subjects: 0
Study 36012027 — intervention group
Group type: COMPARATOR
Intervention: General educational sessions on food and health, 3 sessions
Number of subjects: 0
Study 33867498 — intervention group
Group type: EXPERIMENTAL
Intervention: AERO‐PA (aerobic training and increasing nonexercise physical activity)
Number of subjects: 45
Study 33867498 — intervention group
Group type: EXPERIMENTAL
Intervention: AERO (aerobic training)
Number of subjects: 45
Study 33867498 — intervention group
Group type: COMPARATOR
Intervention: CON (control group)
Number of subjects: 45
Study 33867498 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in steps (AERO‐PA)
Number of subjects: 45
Study 36165989 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint interval training at 0% incline
Number of subjects: 65
Study 36165989 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint interval training at 6% incline
Number of subjects: 65
Study 33767062 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy (e.g., percutaneous coronary intervention or coronary artery bypass graft)
Number of subjects: 0
Study 33767062 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy with maximal medical management
Number of subjects: 0
Study 32092887 — intervention group
Group type: COMPARATOR
Intervention: 400 IU daily vitamin D3
Number of subjects: 373
Study 32092887 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU daily vitamin D3
Number of subjects: 373
Study 32092887 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 IU daily vitamin D3
Number of subjects: 373
Study 35472115 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular Dermal Matrix (ADM)
Number of subjects: 20
Study 35472115 — intervention group
Group type: COMPARATOR
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 20
Study 33935080 — intervention group
Group type: EXPERIMENTAL
Intervention: BrainUp-10®
Number of subjects: 82
Study 33935080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 35850363 — intervention group
Group type: EXPERIMENTAL
Intervention: NBTXR3 (single intratumoral injection, volume equivalent to 10% of baseline tumor volume, at 53.3 g/L) plus external-beam RT (50 Gy in 25 fractions)
Number of subjects: 179
Study 35850363 — intervention group
Group type: COMPARATOR
Intervention: External-beam RT alone (50 Gy in 25 fractions)
Number of subjects: 179